-
Spine
OssDsign appoints Tom Buckland as Chief Technical Officer
February 29, 2024 – OssDsign AB (publ.) today announces that the company’s current VP of Strategy, Business Development and Regulatory…
Read More » -
Financial
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…
Read More » -
Recon
Father of Exactech Employee Receives First Ankle Replacement Using Activit-E™ Polyethylene
Exactech’s Activit-E for the Vantage Ankle is a next-generation highly crosslinked polyethylene with vitamin E antioxidant stabilization. GAINESVILLE, Fla., Feb. 29,…
Read More » -
Financial
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
— Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA of $214 million — — EXPAREL…
Read More » -
Financial
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
FY 2023 Third Party Net Sales from Continuing Operations of $457.2 million FY 2023 Third Party Net Sales from Discontinued…
Read More » -
Financial
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights
Full year 2023 total revenue grew 37% to $482 million Full year 2023 adjusted EBITDA margin improved ~890 basis points…
Read More » -
Recon
Osso VR Welcomes Greg Born as CEO to Lead Growth Efforts in Immersive Procedural Training Space
Seasoned technology executive will focus on scaling and growth for the VR training platform, while co-founder Justin Barad, MD steps into…
Read More » -
Financial
Mainstay Medical Announces US$125 Million Equity Financing Transaction
Funding to accelerate commercial growth and expand clinical and health economic evidence for ReActiv8® Restorative Neuromodulation™ System DUBLIN, February 26, 2024…
Read More » -
Financial
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving…
Read More » -
Financial
Aclarion Announces Pricing of $3.0 Million Public Offering
BROOMFIELD, CO, Feb. 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology…
Read More »